DEFINITIVE PROXY STATEMENT

Company

Pasithea Therapeutics Corp.

Filed

May 13, 2022

Period of Report

June 23, 2022

Accession Number

0001213900-22-026293

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →